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Abstract
Background: A well targeted flu vaccine strategy can ensure that vaccines go to those who are at the highest risk of getting
infected if unvaccinated. However, prior research has not explicitly examined the association between the risk of flu
infection and vaccination rates.
Purpose: This study examines the relationship between the risk of flu infection and the probability of getting vaccinated.
Methods: Nationally representative data from the US and multivariate regression models were used to estimate what
individual characteristics are associated with (1) the risk of flu infection when unvaccinated and (2) flu vaccination rates.
These results were used to estimate the correlation between the probability of infection and the probability of getting
vaccinated. Separate analyses were performed for the general population and the high priority population that is at
increased risk of flu related complications.
Results: We find that the high priority population was more likely to get vaccinated compared to the general population.
However, within both the high priority and general populations the risk of flu infection when unvaccinated was negatively
correlated with vaccination rates (r=20.067, p,0.01). This negative association between the risk of infection when
unvaccinated and the probability of vaccination was stronger for the high priority population (r=20.361, p,0.01).
Conclusions: There is a poor match between those who get flu vaccines and those who have a high risk of flu infection
within both the high priority and general populations. Targeting vaccination to people with low socioeconomic status,
people who are engaged in unhealthy behaviors, working people, and families with kids will likely improve effectiveness of
flu vaccine policy.
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Introduction
Seasonal influenza is associated with a large number of
hospitalizations and excess deaths in the United States [1–3].
Annual vaccination is the most effective strategy for preventing
influenza infection. The Advisory Committee on Immunization
Practices (ACIP) recommends influenza vaccination for all people
age 6 months and older, with a focus on priority populations with
a high risk of complications (e.g. older adults, people with certain
medical conditions, and pregnant women) and those that come in
frequent contact with these populations (e.g. healthcare profes-
sionals) [4]. Despite these recommendations, influenza vaccination
coverage is still suboptimal. In the 2009–2010 flu season, the
national seasonal influenza vaccination coverage among the adult
population was 36%, ranging from 28% for adults 18–49 years old
without high risk of complications to 68% for adults aged 65 and
older [5].
The emergence of new influenza subtypes and antigenic
evolution of influenza requires annual updates of the influenza
vaccine, which sets a tight schedule for manufacturers to produce
sufficient doses. A delay in the schedule can cause shortage of
influenza vaccines available for distribution [6]. Contaminated flu
vaccines caused a vaccine shortage in the U.S. in the 2004–2005
flu season [7]. More recently, the U.S. faced a shortage of seasonal
flu vaccine as well as swine flu vaccine in the 2009–2010 flu season
as the H1N1 pandemic raised the demand of flu vaccines well
beyond the manufacturers’ production capacity [8]. In a flu
vaccine shortage, people who need a vaccine may not be able to
obtain one. An optimal flu vaccine distribution strategy is
imperative to make sure the limited vaccines go to those who
need them most.
Several prior studies have examined the correlates of flu
vaccination. The vast majority of this literature has focused on
priority populations such as the elderly and healthcare workers.
Significant predictors of flu vaccination among priority popula-
tions include perceived effectiveness and safety of vaccines, as well
as beliefs about own health status and risk of infection [9–18].
There is concern that some of these beliefs might be mistaken. For
example, some consumers have the mistaken assumption that
healthy people do not need immunization, while others believe
that vaccination can cause serious side effects [10–11,15,17,19–
23]. Important barriers to vaccination include lack of insurance
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15,21–25]. Several studies also document racial disparities in
vaccination coverage with African Americans and Hispanics
having lower vaccination rates compared to Whites [15,21,24,
26–38]. Some studies have also shown that those with unhealthy
lifestyles are less likely to be vaccinated [39–41].
There are only a few studies that examine the correlates of flu
vaccination in the general population. One study using a national
sampleofadultsfromtheU.S.aged50–64yearsfoundthatprevious
doctor visits, education and perceived vaccine effectiveness and
safety were important predictors of flu coverage [42]. Two studies
using a national sample of adults from Canada and Korea found
that physician or nurse recommendation was the major predictor of
vaccination [43–44]. Other studies on vaccination coverage among
the general population have relied on much smaller samples from a
few employers or communities [45–47].
While the prior literature documents some important predictors
of flu vaccination, it does not explicitly examine whether those
receiving the flu vaccine have a higher risk of infection were they
not vaccinated. A positive association between risk of infection and
vaccination would suggest that the current vaccination program is
well targeted. Conversely, a negative association would suggest
poor targeting. Thus, examining the association between risk of
infection and vaccination is an important metric for evaluating
the effectiveness of the current flu vaccination program. This
information is also important for developing an optimal vaccina-
tion strategy, especially given the vaccine shortages experienced in
recent flu seasons and the suboptimal vaccination rate among both
the general and high priority populations. In this paper, we
addresses this gap in the literature by using nationally represen-
tative data from the U.S. to examine the association between risk
of flu infection when unvaccinated and vaccination rates among
both the general and high priority populations.
Methods
Data
The study used data from the 2007 National Health Interview
Survey (NHIS) to examine the correlates of flu vaccination and flu
infection. NHIS is a cross-sectional household interview survey
that uses a national representative sample of the civilian nonin-
stitutionalized population of the United States. The sample for
analysis was restricted to sample adults aged 18 years and older.
The analysis used the 2007 wave of NHIS for analysis because it is
the only wave that asked about both flu vaccination and infection
(other waves have asked about flu vaccination only).
Outcome Measures
Respondents in the 2007 NHIS were asked ‘‘Have you ever been
told by a doctor or other health professional that you had influenza
or pneumonia?’’ If the answer is yes, the respondents were asked
‘‘During the past 12 months, have you had influenza or
pneumonia?’’ Respondents were coded as having had the flu in
the past 12 months if they answered yes to both of the above two
questions. Flu vaccination status was determined by the two
following questions: ‘‘During the past 12 months, have you had a flu
shot? A flu shot is usually given in the fall and protects against
influenza for the flu season.’’ and ‘‘During the past 12 months, have
you had a flu vaccine sprayed in your nose by a doctor or other
health professional? A health professional may have let you spray it.
Thisvaccineisusuallygiveninthefalland protectsagainstinfluenza
for the flu season. This influenza vaccine is called FluMist.’’
Respondents were coded as having had a flu vaccine in the past 12
months if they answered yes to either of the two questions.
Explanatory Variables
Based on prior research several groups of explanatory variables
were included in the statistical analysis, including demographics,
family composition, health status, health insurance and health
behaviors. Demographic variables included gender, age, race and
ethnicity, marital status, education and working status, number of
adults and number of kids in the family. Health insurance was
measured by whether respondents were covered by any health
insurance. Health behaviors and measures included self reported
health status(poor to excellent), obesity status (underweight, normal
weight, overweight, obese), smoking and drinking status, physical
exercise, regular strength training, and whether the respondent
reported having a regular place to go for preventive medical care.
Heavy drinking was defined as over 14/7 (male/female) drinks per
week in the past year. Moderate drinking was defined as 1–14/1–7
(male/female) drinks per week in the past year. Respondents were
asked about their time spent on rigorous and moderate physical
exercise per week. Respondents were coded as physically active
(dummy variable set to 1) if they had at least 150 minutes of physical
exercise per week (assuming 1 minute of rigorous exercise is
equivalent to 2 minutes of moderate exercise based on CDC
guidelines [48] ). Respondents were considered to do regular strength
training if they had at least one strength training session per week.
Statistical Analysis
The pattern of flu vaccination and infection could be quite
different across low and high priority groups for flu immunization
as recommendations from ACIP for high priority groups can
potentially influence provider and consumer behavior with regard
to flu vaccination. Therefore, a separate statistical analysis was
conducted for each of the two groups. Consistent with the CDC
definition, people in the high priority group included people aged
65 and older, pregnant women, healthcare workers and anyone
with at least one of the following medical conditions: asthma,
neurological and neurodevelopmental conditions, COPD/emphy-
sema, diabetes, coronary artery disease, HIV/AIDS, cancer and
kidney and liver disorders [49].
For each group the association between risk of flu infection and
the probability of receiving flu vaccination was examined. The
analysis sample for examining the risk of flu infection was
restricted to respondents who did not receive a flu vaccine in the
past 12 months. The analysis started by comparing the average
rate of infection and vaccination by key explanatory variables and
used one-way Analysis of Variance (ANOVA) to test the equality
of infection and vaccination rate across different groups. Next,
multivariate regression analysis was used to test if the associations
documented in the initial comparison of means were robust to
inclusion of multiple covariates. Ideally, one wants to observe flu
infection status for everyone in the sample conditional on not
taking the flu vaccine. In reality, however, one cannot observe this
counterfactual infection status for people who actually did take flu
vaccine. Therefore, studying the risk of infection using infection
information from the subsample of respondents who chose not to
get vaccinated might produce biased estimates. The reason is that
the decision to get vaccinated might be correlated with
unobservable factors that influence the risk of infection. To
address this selection bias, the analysis used a Heckman Probit
model with selection, which jointly estimates the probability of not
being vaccinated (the selection equation) and the probability of flu
infection (the outcome equation) and allows for both decisions to
be correlated based on observable as well as unobservable factors
[50–51]. The dependent variables in the analysis are indicator
variables for whether the respondent was vaccinated in the past 12
months and whether the respondent got flu infection in past 12
Do People Taking Flu Vaccines Need Them the Most?
PLoS ONE | www.plosone.org 2 December 2011 | Volume 6 | Issue 12 | e26347months. Separate regressions were estimated for each priority
group. The results from these regression models were used to
predict the probability of flu infection if unvaccinated and the
probability of flu vaccination for each respondent. Finally, the
correlation between these probabilities was estimated. The
statistical analysis was conducted using Stata SE 11.0 (StataCorp,
College Station, TX).
Results
Summary Statistics
The final analytic sample had 23,393 adults aged 18 and older.
The high priority group accounted for 43 percent of the entire
sample. The rest of them were designated as ‘‘low priority group’’.
Table 1 lists the weighted summary statistics of the sample.
Compared with the low priority group, people in the high priority
group had a substantially higher rate of flu infection (7% vs. 4%).
Readers are reminded that the flu infection rate was calculated for
people who did not take flu vaccine in the past 12 months. People
in the high priority group were more likely to be vaccinated (48%
vs. 18%), which is consistent with the ACIP recommendations.
ANOVA Model
Table 2 presents the rate of flu infection and vaccination by select
explanatory variables (see table S1 for all explanatory variables). An
important observation from table 2 is that many of these variables
Table 1. Summary Statistics of the Analytical Sample.
Variables Low Priority Group High Priority Group Combined
Mean S.D. Mean S.D. Mean S.D.
Had Flu in Past 12 Months 0.04 0.20 0.07 0.25 0.05 0.22
Had Flu Vaccine in Past 12 Months 0.18 0.38 0.48 0.50 0.30 0.46
Age 38.80 12.74 56.39 18.50 45.79 17.55
Male 0.53 0.50 0.41 0.49 0.48 0.50
Race & Ethnicity: Non-Hispanic White 0.66 0.47 0.75 0.43 0.69 0.46
Race & Ethnicity: Black 0.12 0.32 0.11 0.32 0.12 0.32
Race & Ethnicity: Hispanics 0.16 0.37 0.10 0.29 0.13 0.34
Race & Ethnicity: Non-Hispanic Others 0.06 0.24 0.04 0.21 0.06 0.23
Married 0.63 0.48 0.62 0.49 0.62 0.48
Education: Less than High School 0.14 0.35 0.18 0.39 0.16 0.36
Education: High School Graduate 0.28 0.45 0.30 0.46 0.29 0.45
Education: Some College 0.29 0.45 0.28 0.45 0.28 0.45
Education: College Graduate and Above 0.29 0.45 0.24 0.43 0.27 0.44
Number of Adults in Family 2.14 0.94 2.00 0.84 2.08 0.90
Number of Kids in Family 0.86 1.18 0.46 0.97 0.70 1.12
Worked in the Past 12 Months 0.84 0.36 0.51 0.50 0.71 0.45
Covered by Any Health Insurance 0.79 0.41 0.90 0.30 0.83 0.37
Health: Excellent 0.36 0.48 0.18 0.38 0.29 0.45
Health: Very Good 0.35 0.48 0.27 0.44 0.32 0.47
Health: Good 0.23 0.42 0.31 0.46 0.26 0.44
Health: Fair or Poor 0.06 0.23 0.25 0.43 0.13 0.34
BMI: Normal Weight 0.39 0.49 0.34 0.47 0.37 0.48
BMI: Underweight 0.02 0.13 0.02 0.14 0.02 0.13
BMI: Overweight 0.36 0.48 0.35 0.48 0.35 0.48
BMI: Obese 0.24 0.43 0.30 0.46 0.26 0.44
Use Preventive Medical Care 0.85 0.36 0.94 0.23 0.89 0.32
Smoking: Non-Smoker 0.79 0.41 0.83 0.38 0.80 0.40
Smoking: Light Smoker (Someday Only) 0.05 0.22 0.03 0.18 0.04 0.20
Smoking: Heavy Smoker (Everyday) 0.16 0.37 0.14 0.35 0.15 0.36
Drinking: Non-Drinker 0.33 0.47 0.48 0.50 0.39 0.49
Drinking: Light/Moderate Drinker 0.61 0.49 0.48 0.50 0.56 0.50
Drinking: Heavy Drinker 0.06 0.24 0.04 0.19 0.05 0.22
Physical Exercise: .=150 Min/Wk 0.44 0.50 0.34 0.47 0.40 0.49
Regular Strength Training 0.26 0.44 0.18 0.39 0.23 0.42
Observations 13,406 9,987 23,393
Note: Summary statistics were weighted using survey weights. Missing values were excluded from calculations.
doi:10.1371/journal.pone.0026347.t001
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rates. In both priority groups, people with a college degree had a
higher rate of vaccination than those less well educated, although
they were no more likely to contract flu if unvaccinated. In fact, the
college educated had a lower infection rate in the high priority
group. People with kids in their family had a higher infection rate
but they had a significantly lower vaccination rate. Working people
in the high priority group were much less likely to take flu vaccine
even though they had a greater risk of infection without a vaccine.
In both the high and low priority groups, people with health
insurancehad a substantially highervaccinationrate(21% vs. 8%in
low priority group and 52% vs. 18% in high priority group) but the
insured enjoyed a much lower rate of flu infection if unvaccinated.
Similarly, people who had a regular place to go for preventive
medical care were almost three times more likely to immunize but
wereless likely to contract flu. Health behaviors were also associated
with divergent impacts on flu immunization and infection rates. In
both priority groups, heavy smokers were far less likely to vaccinate
and more likely to contract flu than non-smokers or light smokers.
This trend was especially strong in the high priority group. Heavy
drinkers were less likely to get vaccinated in both groups. Heavy
drinkers in the high priority group also had a higher flu infection
rate. In the low priority group, physically active people (time for
physical activities .=150 min/wk) and people who did regular
strength training had a higher rate of vaccination but the same rate
of infection, compared with people with a lower level of physical
activity. For the high priority group, the difference in infection and
vaccination by physical activity level was barely noticeable.
Table 2. Percentage of Flu Infection and Vaccination by Select Individual Characteristics.
Variables Low Priority Group High Priority Group
Flu Infection Flu Vaccination Flu Infection Flu Vaccination
% P %P %P %P
Education: Less Than High School 4.41 13.15 6.92 46.47
Education: High School Graduate 3.73 0.436 15.44 0.000 6.47 0.170 48.69 0.001
Education: Some College 4.31 17.31 7.73 46.79
Education: College Graduate and Above 4.53 23.77 5.53 51.80
2 or Less Adults in Family 4.21 0.818 18.62 0.001 7.10 0.029 50.11 0.000
More Than 2 Adults in Family 4.10 15.99 5.20 40.77
No Kid in Family 4.02 0.364 20.05 0.000 5.87 0.001 53.33 0.000
At Least One Kid in Family 4.37 15.49 8.51 33.16
Not Working in the Past 12 Months 4.39 0.591 18.44 0.612 5.67 0.017 57.87 0.000
Working in the Past 12 Months 4.11 17.97 7.41 39.38
No Health Insurance Coverage 4.93 0.033 7.58 0.000 8.98 0.005 17.61 0.000
Has Health Insurance Coverage 3.96 20.89 6.23 51.73
Health: Excellent 3.25 18.00 4.06 40.60
Health: Very Good 4.21 0.000 18.49 0.464 5.20 0.000 49.02 0.000
Health: Good 4.58 17.69 6.80 49.98
Health: Fair or Poor 8.26 16.21 10.57 51.47
BMI: Normal Weight 3.50 17.21 5.24 48.09
BMI: Underweight 6.51 0.018 19.13 0.160 4.80 0.024 44.33 0.022
BMI: Overweight 4.44 18.98 7.39 50.58
BMI: Obese 4.81 17.89 7.66 46.98
No Regular Place for Preventive Medical Care 5.22 0.016 7.27 0.000 7.55 0.450 18.43 0.000
Regular Place for Preventive Medical Care 3.98 19.90 6.63 50.33
Smoking: Non-Smoker 3.70 19.83 5.44 51.84
Smoking: Light Smoker (Someday Only) 5.16 0.000 13.52 0.000 8.31 0.000 36.54 0.000
Smoking: Heavy Smoker (Everyday) 6.11 10.95 11.48 31.17
Drinking: Non-Drinker 4.45 18.18 6.36 50.40
Drinking: Light/Moderate Drinker 4.26 0.399 18.63 0.015 6.72 0.023 47.77 0.000
Drinking: Heavy Drinker 3.28 14.40 11.03 33.75
Physical Exercise: ,150 Min/Wk 4.12 0.741 16.60 0.000 6.75 0.869 48.86 0.223
Physical Exercise: .=150 Min/Wk 4.25 19.74 6.63 47.57
No Regular Strength Training 4.17 0.857 17.10 0.000 6.87 0.308 48.07 0.127
Regular Strength Training 4.25 20.64 5.92 50.07
Note: P indicates P-value associated with one-way ANOVA. Percentage calculations were weighted using survey weights. Only select individual characteristics were
reported. See table S1 in supplemental information for a full table.
doi:10.1371/journal.pone.0026347.t002
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Table 3 reports the marginal effects of select explanatory
variables on the risk of flu infection when unvaccinated and the
probability of flu vaccination from the Heckman probit regression
analysis (see table S2 for all explanatory variables in the regression
model). The results from the multivariate regression analysis were
largely consistent with the results from the univariate analysis
reported earlier. In both priority groups, college graduates were
significantly more likely to vaccinate compared to those with no
high school diploma. However, the risk of infection did not vary
significantly by education. People with more kids in their family
were significantly more likely to contract the flu but were less likely
to get vaccinated. Similarly, working people had a significantly
higher infection rate but they had a lower vaccination rate in the
high priority group. People covered by health insurance were
significantly more likely to vaccinate but did not have a higher risk
of flu infection. Those with a regular place to go for preventive
medical care were significantly more likely to vaccinate but had a
lower risk of infection in the low priority group. All health
behavior factors were significant predictors of flu vaccination.
Non-smokers were substantially more likely to get flu vaccine and
less likely to get flu, compared with the heavy smokers. Similarly,
non-drinkers and moderate drinkers were significantly more likely
to get vaccinated and they enjoyed a significantly lower risk of
infection in the high priority group. Physically active people and
people with regular strength training were also significantly more
likely to vaccinate, although the effect of physical activities was not
significant in the high priority group. There was no significant
difference in risk of infection by either physical activity level or
strength training level.
Table 3. Marginal Effect of Select Factors Associated with Flu Vaccination and Infection.
Variables Low Priority Group High Priority Group
Infection Vaccination Infection Vaccination
Education [Less Than High School]
High School Graduate 20.008 20.005 20.005 0.018
(0.006) (0.012) (0.010) (0.014)
Some College 0.007 0.005 0.004 0.057***
(0.006) (0.012) (0.010) (0.015)
College Graduate and Above 0.007 0.027** 0.003 0.064***
(0.007) (0.012) (0.011) (0.016)
Worked in the Past 12 Months 0.009* 0.004 0.014* 20.025**
(0.006) (0.009) (0.008) (0.012)
Number of Kids in Family 0.003* 20.009*** 0.007** 20.012*
(0.002) (0.003) (0.003) (0.006)
Covered by Any Health Insurance 20.008 0.091*** 20.015 0.159***
(0.005) (0.010) (0.010) (0.020)
Regular Place for Preventive Medical Care 20.012** 0.072*** 20.018 0.158***
(0.006) (0.012) (0.012) (0.024)
Smoking Status [Current Smoker, Everyday]
Non-Smoker 20.016*** 0.047*** 20.032*** 0.069***
(0.005) (0.010) (0.008) (0.015)
Current Smoker, Sometimes 20.009 0.032* 20.022 0.065**
(0.009) (0.018) (0.017) (0.029)
Drinking Status [Current Heavy Drinker]
Current Non-Drinker 0.015 0.032** 20.025* 0.063**
(0.009) (0.016) (0.015) (0.026)
Current Moderate Drinker 0.011 0.019 20.027* 0.088***
(0.009) (0.015) (0.014) (0.026)
Physical Exercise: .=150 Min/Week 0.003 0.017** 0.010 0.008
(0.004) (0.007) (0.008) (0.011)
Strength Training: .=Once/Week 0.004 0.020** 20.003 0.064***
(0.005) (0.008) (0.010) (0.014)
Correlation: Pr(Infection) & Pr(Vaccination) 20.067*** 20.361***
Observations 10,794 13,078 4,952 9,735
Note: Average marginal effects are reported from Heckman probit selection model. The reported correlation is between predicted probability of flu infection conditional
on being not vaccinated and predicted probability of flu vaccination. Group in the brackets is the reference group. Only select variables in the regression model were
reported. See table S2 in supplemental information for a full table. Significance:
*p,0.10,
**p,0.05,
***p,0.01.
doi:10.1371/journal.pone.0026347.t003
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infection and vaccination. Men had lower odds for both flu infection
and vaccination than women. Compared to non-Hispanic Whites,
Blackswere significantly lesslikelyto get flu vaccine andto getthe flu
when unvaccinated. Hispanics were less likely to get vaccinated,
howevertheirriskofinfectionriskwasnotsignificantlydifferentfrom
non-Hispanic Whites. Self-reported health status was a significant
predictor of flu infection. In contrast with other factors, poor health
wasassociatedwithbothhigherriskoffluinfectionandhigherrateof
vaccination. Similarly, obese people had a higher probability of both
flu infection and vaccination in the high priority group.
Correlation between Probabilities of Infection and
Vaccination
The results from these regression models were used to predict
the probability of flu infection when unvaccinated, and the
probability of flu vaccination for each respondent. In both priority
groups, the risk of flu infection and the probability of vaccination
were negatively correlated; and the correlations were significant at
0.01 level. A much stronger negative correlation was observed in
the high priority group than the low priority group (20.36 vs.
20.07). In other words, within each priority group, people who
had a higher predicted risk of infection also had a lower predicted
probability of vaccination and this trend was much stronger in the
high priority group. For example, in the low priority group, the
average probability of flu infection was 0.044 for the lowest
quartile of the probability of vaccination vs. 0.039 for the highest
quartile. In the high priority group, the average probability of flu
infection was 0.079 for the lowest quartile of the probability of
vaccination vs. 0.040 for the highest quartile.
Discussion
This study examined the correlates of flu infection and
vaccination simultaneously using the same set of explanatory
variables. The analysis suggests that, within each priority group,
many people with a higher propensity to vaccinate actually had a
lower probability of contracting the flu if unvaccinated. Specifi-
cally, people with more social resources (higher education, health
insurance coverage) and people who took good care of their health
(physically active people, non-smokers, non-drinkers and those
who use preventive care) were more motivated to protect them-
selves from flu through vaccination, even though they had a lower
risk of infection. In contrast, people with more kids in their family
and people who work for pay were at greater risk of infection but
were less likely to vaccinate. In general, for each priority group, we
need additional programs that target specific population groups
that have a higher risk of infection and a lower propensity to
vaccinate. Under an optimal flu vaccination policy, one would
expect a strong positive correlation between the risk of infection
and probability of vaccination, that is, people at a higher risk of
infection should have a higher vaccination rate. However, the
results from this study suggest that the opposite is true within each
priority group: people who had a higher propensity to vaccinate
were the same people who were at lower risk of infection. And this
mismatch between risk of infection and vaccination rates was
much worse in the high priority group, who are more vulnerable
to flu-related complications. The only silver lining in the results
was that the high priority group had higher vaccination rates
compared to the low priority group.
A major strategy to improve flu vaccine allocation reported by
previous studies is to vaccinate potential ‘‘super-spreaders’’ like
older children and younger adults [52–60]. Our analysis concurs
with this strategy in that adults with kids living in the family are
significantly more likely to get flu infection but less likely to
vaccinate. However, our analysis suggests that having kids in the
family is just one of the many factors that have divergent effects on
flu vaccination and flu infection. While vaccinating older children
and younger adults can potentially reduce the source of infection,
many people at higher risk of flu infection are still not vaccinated.
Overall the empirical evidence presented in this paper suggests
several other ways to address and improve the effectiveness of
current flu vaccination programs. First, we should make efforts to
improve the vaccination rate among people with low socioeco-
nomic status and few social resources such as minorities, people
without insurance coverage and the less educated. Second, we
should have an outreach program to target people who are
engaged in unhealthy behaviors such as heavy smokers, heavy
drinkers, and people with sedentary lifestyles. Third, we should
encourage everyone in families with kids to vaccinate. Finally,
we should improve flu vaccination at the workplace. However,
targeting people who need flu vaccination the most may be a
difficult endeavor. Alternatively, a universal flu vaccination pro-
gram that offers free flu vaccines to all individuals can improve
vaccination rate, as demonstrated by evidence from the universal
flu immunization program introduced in Ontario, Canada in 2000
[61]. However, a universal flu immunization program may pro-
duce disparate impacts on different population groups. The
program may effectively boost the flu vaccine uptake in people
who are unvaccinated for cost reasons, such as low-income or
uninsured population. But the effectiveness of such a program
among people with unhealthy lifestyles is questionable. Unhealthy
lifestyles often reveal people’s attitude toward risk-taking and
preference for investments in health, which are unlikely to be
responsive to a lower cost of flu vaccine. For this group, a targeted
vaccine program that includes both subsidies and educational
and behavioral interventions may be necessary. Comparing the
effectiveness of each of these and other strategies for targeting flu
vaccines is an important topic for future research. Additionally,
future research can build upon this analysis and explore the impact
of other factors on both flu infection and vaccination, such as
adoption of other preventive behaviors during the flu season (e.g.
washing hands more frequently, avoiding contact with people with
flu-like symptoms and avoiding public transportation or other
crowded places), preferences or attitudes towards risks, influence of
peers, and cultural attitudes towards modern medicine and disease
processes.
The findings of this study should be viewed in light of its
limitations. Although the study uses nationally representative data,
the data have some shortcomings. First, flu infections were self-
reported. The study was not able to verify and measure the level of
misreporting as the official annual flu season summary prepared
by CDC only reports the weekly percentage of patient visits to
physicians for influenza-likely illness [62]. Second, the survey was
conducted continuously during the year 2007, which means the
time period of ‘‘the past 12 months’’ varies depending on the time
of the survey. Third, the flu infection data is available only in the
2007 NHIS survey. Ideally, one would like to study flu vaccination
and infection in other years, especially those years with a flu
pandemic and a flu vaccine shortage. Lastly, as with most popu-
lation-based surveys, we can only use NHIS to track ‘‘influenza
like illness’’. There are two concerns with using this measure to
estimate the correlates of flu infection if unvaccinated. First, in
principle influenza like illness can be caused by several viruses
including the influenza virus. Second, influenza like illness does
not capture infection risk for individuals who only suffer from
asymptomatic flu infection. However, we believe that these are not
significant concerns for several reasons. Prior research shows that
Do People Taking Flu Vaccines Need Them the Most?
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with laboratory-confirmed influenza infection [63]. Prior research
also shows that as much as two thirds of all flu infections are
symptomatic and suggests that the risk of symptomatic flu infection
is highly correlated with the overall risk of flu infection [64]. In
addition, we are not aware of any prior research that highlights
any socioeconomic or demographic factors that predict the risk of
symptomatic flu infection but not asymptomatic infection. Finally,
there is little research that establishes the infectivity of individuals
with asymptomatic infection. However, evidence from studies a-
mong individuals with symptomatic infection show that the in-
fectivity of individuals as measured by viral shedding is highly
positively correlated with the severity of symptoms [65–66].
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